NCT00468936View on ClinicalTrials.gov

Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms

PHASE3UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Heart Transplant Patients
Interventions
DRUG

Myfortic

enteric coated Cellcept pills in applicable dose for patient

Trial Locations (1)

H3A 1A1

RECRUITING

McGill University Health Centre, Montreal

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT00468936 - Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms | Biotech Hunter | Biotech Hunter